These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

438 related articles for article (PubMed ID: 2725104)

  • 1. [Purine transport through the blood-brain barrier in hypoxanthine phosphoribosyltransferase deficiency].
    López Jiménez M; García Puig J; Mateos Antón F; Ramos Hernández T; Pascual Castroviejo I; Ortiz Vázquez J
    Med Clin (Barc); 1989 Feb; 92(5):167-70. PubMed ID: 2725104
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy and safety of allopurinol in patients with hypoxanthine-guanine phosphoribosyltransferase deficiency.
    Torres RJ; Prior C; Puig JG
    Metabolism; 2007 Sep; 56(9):1179-86. PubMed ID: 17697859
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy and safety of allopurinol in patients with the Lesch-Nyhan syndrome and partial hypoxanthine- phosphoribosyltransferase deficiency: a follow-up study of 18 Spanish patients.
    Torres RJ; Prior C; Puig JG
    Nucleosides Nucleotides Nucleic Acids; 2006; 25(9-11):1077-82. PubMed ID: 17065067
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Overproduction of uric acid in hypoxanthine-guanine phosphoribosyltransferase deficiency. Contribution by impaired purine salvage.
    Edwards NL; Recker D; Fox IH
    J Clin Invest; 1979 May; 63(5):922-30. PubMed ID: 447834
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hypoxanthine and xanthine transport through the blood-brain barrier in hypoxanthine phosphoribosyltransferase (HPRT) deficiency.
    Jiménez ML; Puig JG; Mateos FA; Ramos TH; Castroviejo IP; Vázquez JO
    Adv Exp Med Biol; 1989; 253A():173-9. PubMed ID: 2624187
    [No Abstract]   [Full Text] [Related]  

  • 6. The diagnosis of HPRT deficiency in the 21st century.
    Torres RJ; Puig JG
    Nucleosides Nucleotides Nucleic Acids; 2008 Jun; 27(6):564-9. PubMed ID: 18600505
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lesch-Nyhan syndrome and its pathogenesis: purine concentrations in plasma and urine with metabolite profiles in CSF.
    Harkness RA; McCreanor GM; Watts RW
    J Inherit Metab Dis; 1988; 11(3):239-52. PubMed ID: 3148065
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clinical spectrum of hypoxanthine-guanine phosphoribosyltransferase deficiency: study of 12 cases].
    García Puig J; Mateos FA; Jiménez ML; Arcas J; Miranda ME; Oríz Vázquez J
    Med Clin (Barc); 1994 May; 102(18):681-7. PubMed ID: 8028417
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Xanthinuria with xanthine lithiasis in a patient with Lesch-Nyhan syndrome under allopurinol therapy].
    Rebentisch G; Stolz S; Muche J
    Aktuelle Urol; 2004 Jun; 35(3):215-21. PubMed ID: 15258855
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Purine metabolism in female heterozygotes for hypoxanthine-guanine phosphoribosyltransferase deficiency.
    Puig JG; Mateos FA; Torres RJ; Buño AS
    Eur J Clin Invest; 1998 Nov; 28(11):950-7. PubMed ID: 9824441
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of allopurinol on cerebral spinal fluid (CSF) purines in hypoxanthine-guanine phosphoribosyltransferase (HPRT) deficiency syndromes.
    Edwards NL; Puig JG; Mateos FA
    Adv Exp Med Biol; 1986; 195 Pt A():465-9. PubMed ID: 3728180
    [No Abstract]   [Full Text] [Related]  

  • 12. Xanthine-containing calculi during allopurinol therapy.
    Kranen S; Keough D; Gordon RB; Emmerson BT
    J Urol; 1985 Apr; 133(4):658-9. PubMed ID: 3981718
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of allopurinol on beer-induced increases in plasma concentrations and urinary excretion of purine bases (uric acid, hypoxanthine, and xanthine).
    Ka T; Moriwaki Y; Inokuchi T; Yamamoto A; Takahashi S; Tsutsumi Z; Yamamoto T
    Horm Metab Res; 2006 Mar; 38(3):188-92. PubMed ID: 16673211
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma and urinary oxypurines in Lesch-Nyhan patient after allopurinol treatment.
    Roscioni G; Farnetani MA; Pagani R; Pizzichini M; Marinello E; Porcelli B
    Adv Exp Med Biol; 1994; 370():357-61. PubMed ID: 7660928
    [No Abstract]   [Full Text] [Related]  

  • 15. Production of a model for Lesch-Nyhan syndrome in hypoxanthine phosphoribosyltransferase-deficient mice.
    Wu CL; Melton DW
    Nat Genet; 1993 Mar; 3(3):235-40. PubMed ID: 8485579
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Theophylline-induced increase in plasma uric acid--purine catabolism increased by theophylline.
    Yamamoto T; Moriwaki Y; Suda M; Takahashi S; Hiroishi K; Higashino K
    Int J Clin Pharmacol Ther Toxicol; 1991 Jul; 29(7):257-61. PubMed ID: 1889911
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibiting PNP for the therapy of hyperuricemia in Lesch-Nyhan disease: Preliminary in vitro studies with analogues of immucillin-G.
    Jacomelli G; Baldini E; Mugnaini C; Micheli V; Bernardini G; Santucci A
    J Inherit Metab Dis; 2019 Jan; 42(1):178-185. PubMed ID: 30740729
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adenine therapy in Lesch-Nyhan syndrome.
    Bührdel P; Krüger W; Hirschberg K; Wehnert M
    Acta Paediatr Hung; 1985; 26(4):327-33. PubMed ID: 4096858
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma concentrations and urinary excretion of purine bases (uric acid, hypoxanthine, and xanthine) and oxypurinol after rigorous exercise.
    Kaya M; Moriwaki Y; Ka T; Inokuchi T; Yamamoto A; Takahashi S; Tsutsumi Z; Tsuzita J; Oku Y; Yamamoto T
    Metabolism; 2006 Jan; 55(1):103-7. PubMed ID: 16324927
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clearance of oxypurines in normal subjects and in gout patients subjected to a purine-free diet. Effects of allopurinol].
    Porcelli B; Pizzichini M; Di Stefano A; Leoncini R; Taddeo A; Marinello E
    Boll Soc Ital Biol Sper; 1989 Nov; 65(11):1105-10. PubMed ID: 2629828
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.